|
NOTIFICATION
OF MAJOR HOLDINGS (to be sent to the relevant
issuer and
to the FCA in
Microsoft Word format if possible)i
|
|
|
|
1a. Identity of
the issuer or the underlying issuer of existing shares to which
voting rights are attachedii:
|
ARIX Bioscience PLC
|
|
1b. Please
indicate if the issuer is a non-UK issuer (please mark with an “X” if
appropriate)
|
|
Non-UK issuer
|
|
|
2. Reason for the
notification (please mark
the appropriate box or boxes with an “X”)
|
|
An acquisition or disposal of
voting rights
|
|
|
An acquisition or disposal of
financial instruments
|
X
|
|
An event changing the breakdown of
voting rights
|
|
|
Other (please
specify)iii:
|
|
|
3. Details of
person subject to the notification obligationiv
|
|
Name
|
Weiss Asset Management
LP
|
|
City and country of registered
office (if applicable)
|
Wilmington, Delaware,
USA
|
|
4. Full name of
shareholder(s) (if different
from 3.)v
|
|
Name
|
Brookdale International Partners,
L.P., Brookdale Global Opportunity Fund
|
|
City and country of registered
office (if applicable)
|
Brookdale International Partners,
L.P.: Albany, NY, USA
Brookdale Global Opportunity Fund:
Grand Cayman, Cayman Islands
|
|
5. Date on which
the threshold was crossed or reachedvi:
|
January-2-2024
|
|
6. Date on which
issuer notified (DD/MM/YYYY):
|
January-4-2024
|
|
7. Total
positions of person(s) subject to the notification
obligation
|
|
|
% of voting rights attached to
shares (total of 8. A)
|
% of voting rights through
financial instruments
(total of 8.B 1 + 8.B 2)
|
Total of both in % (8.A +
8.B)
|
Total number of voting rights of
issuervii
|
|
Resulting situation on the date on
which threshold was crossed or reached
|
0.00
|
5.19
|
5.19
|
129,389,508
|
|
Position of previous notification
(if
applicable)
|
N/A
|
N/A
|
N/A
|
|
| |
|
|
|
|
|
|
